Although our EV data is supported by studies measuring CD45 cell counts (Jin et al., 2020), we also observed a recovery of CD45+ EV levels in the latter phase of mild COVID‐19 (post‐13 days). The gene discussed is PTPRC; the disease is COVID-19.